Our clients include world's top universities and pharmaceutical organizations
Immunocore
Saturday, September 2, 2023
Immunocore to present at upcoming investor conferences
IMV
Saturday, September 2, 2023
IMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets
Bavarian Nordic
Friday, September 1, 2023
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Amgen
Friday, September 1, 2023
AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION
12th Conference of the International Society for Affective Disorders
Friday, December 15, 2023
Milan, Italy
Science
Friday, September 1, 2023
Intracellular tPA–PAI-1 interaction determines VLDL assembly in hepatocytes
Science
Friday, September 1, 2023
An mTRAN-mRNA interaction mediates mitochondrial translation initiation in plants
Science
Thursday, August 31, 2023
Genomic inference of a severe human bottleneck during the Early to Middle Pleistocene transition
Science
Thursday, August 31, 2023
A machine-learning tool to predict substrate-adaptive conditions for Pd-catalyzed C–N couplings
Nuvectis Pharma
Friday, September 1, 2023
Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
Amylyx Pharmaceuticals
Friday, September 1, 2023
Saskatchewan to Provide Coverage for ALBRIOZA™ for the Treatment of ALS
Karyopharm Therapeutics
Friday, September 1, 2023
Karyopharm Appoints Zhen Su, MD, MBA to its Board of Directors
Coherus BioSciences
Friday, September 1, 2023
Coherus BioSciences to Participate at Upcoming September Investor Conferences
XXVII World Congress and Vulvovaginal Disease Update 2024
Friday, September 13, 2024
Ljubljana, Slovenia
Cell
Thursday, August 31, 2023
Humanized mouse liver reveals endothelial control of essential hepatic metabolic functions
Cell
Thursday, August 31, 2023
The projection-specific signals that establish functionally segregated dopaminergic synapses
Lancet
Thursday, August 31, 2023
Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a registry study
New England Journal of Medicine
Wednesday, August 30, 2023
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors
X4 Pharmaceuticals
Friday, September 1, 2023
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlaxoSmithKline
Friday, September 1, 2023
GSK’s regulatory submission accepted for review by Japanese regulator for use of Nucala (mepolizumab) in adults with chronic rhinosinusitis with nasal polyps
Arvinas
Friday, September 1, 2023
Arvinas to Participate in Upcoming Investor Conferences
Belite Bio
Friday, September 1, 2023
Belite Bio Announces MHRA Submission for Tinlarebant Phase 3 GA Clinical Trial in United Kingdom
New England Journal of Medicine
Wednesday, August 30, 2023
CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease
New England Journal of Medicine
Wednesday, August 30, 2023
Anti–Epstein–Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer
New England Journal of Medicine
Wednesday, August 30, 2023
Timing of Primary Surgery for Cleft Palate
Nature
Wednesday, August 30, 2023
A pentameric TRPV3 channel with a dilated pore
Sarepta Therapeutics
Friday, September 1, 2023
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Supernus Pharmaceuticals
Friday, September 1, 2023
Supernus to Participate in the Wells Fargo Healthcare Conference | Supernus Pharmaceuticals
Lyell Immunopharma
Friday, September 1, 2023
Lyell Immunopharma to Participate in Upcoming Investor Conferences
Valneva SE
Friday, September 1, 2023
Valneva to Participate in Investor Conferences in the United States and Europe in September 2023
Nature
Wednesday, August 30, 2023
Gut microbial carbohydrate metabolism contributes to insulin resistance
Nature
Wednesday, August 30, 2023
Widespread retreat of coastal habitat is likely at warming levels above 1.5 °C
Nature
Wednesday, August 30, 2023
Metabolic programs of T cell tissue residency empower tumour immunity
Nature
Wednesday, August 30, 2023
CRISPR screens decode cancer cell pathways that trigger γδ T cell detection
Arctom is an e-commerce platform that provides 350K+ Building Blocks, Inhibitors, Agonists, Natural Products, PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, research, and industrial customers. We accelerate your research by providing better purchasing experience & services.